Eli Lilly has filed its oral GLP-1 medication orforglipron with the US FDA, aiming to revolutionise diabetes treatment with a tablet that offers manufacturing ease and potential for increased patient access amidst ongoing supply and regulatory challenges. Eli Lilly has…
New research indicates that metformin, traditionally used for type 2 diabetes, could offer protective benefits against rejection and graft failure among kidney transplant recipients on tacrolimus, prompting calls for further investigation into its immunomodulatory effects. Metformin, a long-established first-line treatment…
As diabetes apps attempt to automate carbohydrate counting through photos, experts warn that accuracy remains inconsistent. Meanwhile, the future lies in harnessing personal glucose data, raising urgent questions about data access and patient empowerment. A growing cluster of diabetes apps…
Guidance from health agencies emphasises balance, portion control, and smart food choices to enable people living with diabetes to enjoy seasonal gatherings safely and deliciously. Summer cookouts can be a source of pleasure and pressure in equal measure for people…
SAB Biotherapeutics progresses its lead type 1 diabetes treatment into further testing phases, expands manufacturing capacity, and receives strategic grants amid rising R&D investment and a significant stock index inclusion. SAB Biotherapeutics said its lead type 1 diabetes programme moved…
Scientists at Rice University have created a local immune buffer using IL-10 to protect transplanted pancreatic beta cells, extending their survival in diabetic mice and potentially revolutionising cell therapies for type 1 diabetes. Rice University researchers say they have found…
Research indicates that tirzepatide, the active ingredient in Mounjaro, not only helps control blood sugar and weight but also significantly reduces the risk of heart attacks and serious cardiovascular events in patients with type 2 diabetes and heart disease, signalling…
Women with polycystic ovary syndrome are increasingly using GLP-1 receptor agonists like Ozempic and Mounjaro to manage weight and insulin resistance as part of fertility preparation, raising questions about safety, timing, and long-term outcomes. GLP-1 drugs such as Ozempic, Wegovy…
The short-acting insulin market is forecast to expand significantly by 2030 and 2034, propelled by increasing diabetes prevalence, advances in delivery technology, and strategic industry moves towards biosimilars and product interchangeability. The short-acting insulin market is heading for steady expansion…
A Lausanne study reveals that metabolic health during pregnancy influences how the brain processes food images, with pregnant women with gestational diabetes showing distinct electrical activity patterns within milliseconds of viewing food cues, impacting appetite and eating behaviour. Researchers in…
